These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 26209625
1. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels. Mayeux J, Skaug B, Luo W, Russell LM, John S, Saelee P, Abbasi H, Li QZ, Garrett-Sinha LA, Satterthwaite AB. J Immunol; 2015 Sep 01; 195(5):1955-63. PubMed ID: 26209625 [Abstract] [Full Text] [Related]
2. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. Luo W, Mayeux J, Gutierrez T, Russell L, Getahun A, Müller J, Tedder T, Parnes J, Rickert R, Nitschke L, Cambier J, Satterthwaite AB, Garrett-Sinha LA. J Immunol; 2014 Jul 15; 193(2):909-920. PubMed ID: 24929000 [Abstract] [Full Text] [Related]
3. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice. Whyburn LR, Halcomb KE, Contreras CM, Lowell CA, Witte ON, Satterthwaite AB. J Immunol; 2003 Aug 15; 171(4):1850-8. PubMed ID: 12902486 [Abstract] [Full Text] [Related]
4. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice. Gutierrez T, Mayeux JM, Ortega SB, Karandikar NJ, Li QZ, Rakheja D, Zhou XJ, Satterthwaite AB. Eur J Immunol; 2013 Feb 15; 43(2):382-93. PubMed ID: 23169140 [Abstract] [Full Text] [Related]
5. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. Tsantikos E, Maxwell MJ, Kountouri N, Harder KW, Tarlinton DM, Hibbs ML. J Immunol; 2012 Aug 15; 189(4):1726-36. PubMed ID: 22798664 [Abstract] [Full Text] [Related]
6. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice. Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Lowell CA, Tedder TF. J Immunol; 2001 Sep 01; 167(5):2469-78. PubMed ID: 11509585 [Abstract] [Full Text] [Related]
7. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene. Takeshita H, Taniuchi I, Kato J, Watanabe T. Int Immunol; 1998 Apr 01; 10(4):435-44. PubMed ID: 9620599 [Abstract] [Full Text] [Related]
8. Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Gutierrez T, Halcomb KE, Coughran AJ, Li QZ, Satterthwaite AB. Eur J Immunol; 2010 Jul 01; 40(7):1897-905. PubMed ID: 20394076 [Abstract] [Full Text] [Related]
9. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. Hibbs ML, Harder KW, Armes J, Kountouri N, Quilici C, Casagranda F, Dunn AR, Tarlinton DM. J Exp Med; 2002 Dec 16; 196(12):1593-604. PubMed ID: 12486102 [Abstract] [Full Text] [Related]
10. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways. Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW, Witte ON. J Exp Med; 1998 Sep 07; 188(5):833-44. PubMed ID: 9730885 [Abstract] [Full Text] [Related]
11. Ets1 Controls the Development of B Cell Autoimmune Responses in a Cell-Intrinsic Manner. Sunshine A, Goich D, Stith A, Sortino K, Dalton J, Metcalfe S, Svensson EC, Garrett-Sinha LA. Immunohorizons; 2019 Jul 17; 3(7):331-340. PubMed ID: 31356162 [Abstract] [Full Text] [Related]
12. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency. Verhagen AM, Wallace ME, Goradia A, Jones SA, Croom HA, Metcalf D, Collinge JE, Maxwell MJ, Hibbs ML, Alexander WS, Hilton DJ, Kile BT, Starr R. J Immunol; 2009 Feb 15; 182(4):2020-9. PubMed ID: 19201855 [Abstract] [Full Text] [Related]
13. B cell-specific loss of Lyn kinase leads to autoimmunity. Lamagna C, Hu Y, DeFranco AL, Lowell CA. J Immunol; 2014 Feb 01; 192(3):919-28. PubMed ID: 24376269 [Abstract] [Full Text] [Related]
15. The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus. Kim CJ, Lee CG, Jung JY, Ghosh A, Hasan SN, Hwang SM, Kang H, Lee C, Kim GC, Rudra D, Suh CH, Im SH. Immunity; 2018 Dec 18; 49(6):1034-1048.e8. PubMed ID: 30566881 [Abstract] [Full Text] [Related]
16. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. Scapini P, Hu Y, Chu CL, Migone TS, Defranco AL, Cassatella MA, Lowell CA. J Exp Med; 2010 Aug 02; 207(8):1757-73. PubMed ID: 20624892 [Abstract] [Full Text] [Related]
17. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity. Stoehr AD, Schoen CT, Mertes MM, Eiglmeier S, Holecska V, Lorenz AK, Schommartz T, Schoen AL, Hess C, Winkler A, Wardemann H, Ehlers M. J Immunol; 2011 Sep 15; 187(6):2953-65. PubMed ID: 21859955 [Abstract] [Full Text] [Related]
18. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival. Ferry H, Crockford TL, Silver K, Rust N, Goodnow CC, Cornall RJ. Eur J Immunol; 2005 Dec 15; 35(12):3655-63. PubMed ID: 16278813 [Abstract] [Full Text] [Related]
19. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells. Kersseboom R, Kil L, Flierman R, van der Zee M, Dingjan GM, Middendorp S, Maas A, Hendriks RW. Eur J Immunol; 2010 Sep 15; 40(9):2643-54. PubMed ID: 20623551 [Abstract] [Full Text] [Related]
20. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC. Immunity; 1998 Apr 15; 8(4):497-508. PubMed ID: 9586639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]